|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 498/18 | (2006.01) |
| C07D 498/18 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/439 | (2006.01) |
| (11) | Patento numeris | 3694863 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18795807.9 |
| Europos patento paraiškos padavimo data | 2018-10-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2018/057735 |
| Data | 2018-10-04 |
| (87) | Numeris | WO 2019/073347 |
| Data | 2019-04-18 |
| (30) | Numeris | Data | Šalis |
| 201762570326 P | 2017-10-10 | US | |
| 201862727734 P | 2018-09-06 | US |
| (72) |
BOWLES, Paul , US
ROSE, Peter Robert , US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE |
| CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE |